Role of hepatocyte growth factor and c-Met receptor in neoplastic conditions of salivary glands

Acta Histochemica et Cytochemica

Volumn 38, Issue 1, 2005, Pages 25-30

  Tsukinoki, Keiichi ^a,b   Yasuda, Masanori ^b   Miyoshi, Yoshiko ^a   Mori, Yusuke ^b   Otsuru, Mitsunobu ^b   Saruta, Juri ^a   Sato, Sadao ^a   Kaneko, Akihiro ^b   Watanabe, Yoshibisa ^a   Osamura, Robert Yoshiyuki ^b  

^a KANAGAWA DENTAL COLLEGE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

c Met; HGF; Saliva; Salivary gland; Salivary gland tumor

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; CANCER CELL CULTURE; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FETUS; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; SALIVA LEVEL; SALIVARY GLAND; SALIVARY GLAND TUMOR; TUMOR GROWTH;

EID: 20244373480     PISSN: 00445991     EISSN: None     Source Type: Journal    
DOI: 10.1267/ahc.38.25     Document Type: Review

References (47)

1. Aebersold, D. M., Landt, O., Berthou, S., Gruber, G., Beer, K. T., Greiner, R. H. and Zimmer, Y. (2003) Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx. Oncogene 22; 8519-8523.
2. Amano, O., Matsumoto, K., Nakamura, T. and Iseki, S. (1994) Expression and localization of hepatocyte growth factor in rat submandibular gland. Growth Factors 10; 145-151.
3. Aoki, T., Tsukinoki, K., Karakida, K., Ota, Y., Otsuru, M. and Kaneko, A. (2004) Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis. Oral Oncol. 40; 954-959.
4. Arrieta, O., Garcia, E., Guevara, P., Garcia-Navarrete, R., Ondarza, R., Rembao, D. and Sotelo, J. (2002) Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94; 3210-3218.
5. Bardelli, A., Pugliese, L. and Comoglio, P. M. (1997) "Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection. Biochim. Biophys. Acta 1333; M41-51.
6. Bradley, R. M. (1995) Salivary secretion. In "Essentials of Oral Physiology", St Louis, Mosby, pp. 161-186.
7. Chan, A. M., Rubin, J. S., Bottaro, D. P., Hirschfield, D. W., Chedid, M. and Aaronson, S. A. (1991) Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 254; 1382-1385.
8. Chohen, S. (1960) Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc. Natl. Acad. Sci. USA 46; 302-311.
9. Cohen, S. (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 237; 1555-1562.
10. Cioce, V., Csaky, K. G., Chan, A. M., Bottaro, D. P., Taylor, W. G., Jensen, R., Aaronson, S. A. and Rubin, J. S. (1996) Hepatocyte growth factor (HGF)TNK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J. Biol. Chem. 271; 13110-13115.
11. Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M. and vande Woude, G. F. (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311; 29-33.
12. Costigan, D. C., Guyda, H. G. and Posner, B. I. (1988) Free insulin-like growth factor I (IGF-I) and IGF-II in saliva. J. Clin. Endocrinol. Metab. 66; 1014-1018.
13. Firon, M., Shaharabany, M., Altstock, R. T., Horev, J., Abramovici, A., Resau, J. H., Vande Woude, G. F. and Tsarfaty, I. (2000) Dominant negative Met reduced tumorigenicity-metastasis and increases tubule formation in mammary cells. Oncogene 19; 2386-2397.
14. Furue, M., Okamoto, T., Hayashi, H., Sato, D., Asashima, M. and Saito, S. (1999) Effects of hepatocyte growth factor (HGF) and activin A on the morphogenesis of rat submandibular gland-derived epithelial cells in serum-free collagen cell culture. In Vitro Cell. Dev. Biol. Anim. 35; 131-135.
15. Haddad, R., Lipson, K. E. and Webb, C. P. (2001) Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors. Anticancer Res. 21; 4243-4252.
16. Ishizaki, H., Westermark, A., van Seiten, G. and Pyykko, I. (2000) Basic fibroblast growth factor (bFGF) in saliva-physiological and clinical implication. Acta Otolaryngol. Suppl. 543; 193-195.
17. Karakida, K. (2001) HGF, c-Met and Bcl-2 expression and its role in histogenesis of benign salivary gland tumors. J. Jpn. Stomatol. Soc. 50; 169-181.
18. Lorenzato, A., Olivero, M., Patane, S., Rosso, E., Oliaro, A., Comoglio, P. M. and Di Renzo, M. F. (2002) Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 62; 7025-7030.
19. Maffè, A. and Comoglio, P. M. (1998) HGF controls branched morphogenesis in tubular gland. Eur. J. Morphol. 36; 74-81.
20. Martin, T. A., Parr, C., Davies, G., Watkins, G., Lane, J., Matsumoto, K., Nakamura, T., Mansel, R. E. and Jiang, W. G. (2003) Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24; 1317-1323.
21. Mogi, M., Inagaki, H., Kojima, K., Minami, M. and Harada, M. (1995) Transforming growth factor-alpha in human submandibular gland and saliva. J. Immunoassay 16; 379-394.
22. Moroto, T. and Kamada, A. (1998) Expression and localization of HGF mRNA in monkey submandibular gland. J. Osaka Dent. Univ. 32; 37-42.
23. Nakamura, T., Nawa, K. and Ichihara, A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122; 1450-1459.
24. Noguchi, S., Ohba, Y. and Oka, T. (1991) Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am. J. Physiol. 260; E620-E625.
25. Ohnishi, T. and Daikuhara, Y. (2003) Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues. Arch. Oral Biol. 48; 797-804.
26. Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G. and vande Woude, G. F. (1986) Mechanism of met oncogene activation. Cell 45; 895-904.
27. Park, W. S., Dong, S. M., Kim, S. Y., Na, E. Y., Shin, M. S., Pi, J. H., Kim, B. J., Bae, J. H., Hong, Y. K., Lee, K. S., Lee, S. H., Yoo, N. J., Jang, J. J., Pack, S., Zhuang, Z., Schmidt, L., Zbar, B. and Lee, J. Y. (1999) Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res. 59; 307-310.
28. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G. and Comoglio, P. M. (1994) A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77; 261-271.
29. Ponzetto, C., Pante, G., Prunotto', C., Ieraci, A. and Maina, F. (2000) Met signaling mutants as tools for developmental studies. Int. J. Dev. Biol. 44; 645-653.
30. Rodrigues, G. A., Naujokas, M. A. and Park, M. (1991) Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol. Cell. Biol. 11; 2962-2970.
31. Schmassmann, A., Stettler, C., Poulsom, R., Tarasova, N., Hirschi, C., Flogerzi, B., Matsumoto, K., Nakamura, T. and Halter, F. (1997) Role of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology 113; 1858-1872.
32. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E. and Birchmeier, C. (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373; 699-702.
33. Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., Vocke, C., Brown, J. A., Jenkins, R., Richard, S., Bergerheim, U., Gerrard, B., Dean, M., Linehan, W. M. and Zbar, B. (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18; 2343-2350.
34. Seifert, G. and Sobin, L. H. (1991) Histological typing of salivary gland tumours: World Health Organization International Histological Classification of Tumours, 2nd ed., Springer Verlag, Berlin, pp. 11-13.
35. Suzuki, K., Cheng, J. and Watanabe, Y. (2003) Hepatocyte growth factor and c-Met (HGF/c-Met) in adenoid cystic carcinoma of the human salivary gland. J. Oral Pathol. Med. 32; 84-89.
36. Taichman, N. S., Cruchley, A. T., Fletcher, L. M., Hagi-Pavli, E. P., Paleolog, E. M., Abrams, W. R., Booth, V., Edwards, R. M. and Malamud, D. (1998) Vascular endothelial growth factor in normal human salivary glands and saliva: A possible role in the maintenance of mucosal homeostasis. Lab. Invest. 78; 869-875.
37. To, C. T. and Tsao, M. S. (1998) The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers (Review). Oncol. Rep. 5; 1013-1024.
38. Toi, M., Tanoguchi, T., Ueno, T., Asano, M., Funata, N., Sekiguchi, K., Iwanari, H. and Tominaga, T. (1998) Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin. Cancer Res. 4; 659-664.
39. Tsukinoki, K., Yasuda, M., Asano, S., Karakida, K., Ota, Y., Osamura, R. Y. and Watanabe, Y. (2003) Association of hepatocyte growth factor expression with salivary gland tumor differentiation. Pathol. Int. 53; 815-822.
40. Tsukinoki, K., Suzuki, K., Hori, M., Karakida, K., Yasuda, M., Asano, S. and Watanabe, Y. (2004) The role of cell growth factors in saliva, salivary glands and salivary gland tumors. Bul. Kanagawa Dent. Col. 32; 63-67.
41. Tsukinoki, K., Yasuda, M., Mori, Y., Asano, S., Naito, H., Ota, Y., Osamura, R. Y. and Watanabe, Y. (2004) Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma. Oncol. Rep. 12; 1017-1021.
42. Tuck, A. B., Park, M., Sterns, E. E., Boag, A. and Elliott, B. (1996) Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148; 225-232.
43. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T. and Kitamura, N. (1995) Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373; 702-705.
44. Wang, Y., Selden, A. C., Morgan, N., Stamp, G. W. H. and Hodogson, H. J. F. (1994) Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am. J. Pathol. 144; 675-682.
45. Yamaguchi, M., Abiko, Y., Nishimura, M., Saitoh, M. and Kaku, T. (2004) An immunohistochemical study of the localization of inducible nitoric oxide synthase (iNOS) and heat shock protein (HPS) in pleomorphic adenoma. Acta Histochem. Cytochem. 37; 267-271.
46. Yamauchi, M., Kataoka, H., Itoh, H., Seguchi, T., Hasui, Y. and Osada, Y. (2004) Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma. J. Urol. 171; 890-896.
47. Zang, Y. W. and vande Woude, G. F. (2003) HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell. Biochem. 88; 408-417.